Comparison of the induction of P-glycoprotein activity by nucleotide, nucleoside, and non-nucleoside reverse transcriptase inhibitorsWEISS, Johanna; WEIS, Nicola; KETABI-KIYANVASH, Nahal et al.European journal of pharmacology. 2008, Vol 579, Num 1-3, pp 104-109, issn 0014-2999, 6 p.Article

A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicidesVAN HERREWEGE, Yven; VANHAM, Guido; MICHIELS, Jo et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 10, pp 3684-3689, issn 0066-4804, 6 p.Article

The rise and fall of triple nucleoside reverse transcriptase inhibitor (NRTI) regimensARRIBAS, Jose R.Journal of antimicrobial chemotherapy (Print). 2004, Vol 54, Num 3, pp 587-592, issn 0305-7453, 6 p.Article

Nonnucleoside Reverse Transcriptase Inhibitor Concentrations During Treatment Interruptions and the Emergence of Resistance: A Substudy of the ISS-PART TrialPIRILLO, Maria; PALMISANO, Lucia; VELLA, Stefano et al.AIDS research and human retroviruses. 2010, Vol 26, Num 5, pp 541-545, issn 0889-2229, 5 p.Article

Effect of Nucleoside and Nucleotide Analog Reverse Transcriptase Inhibitors on Cell-Mediated Immune FunctionsENOMOTO, Laura; ANDERSON, Peter L; SHAOBING LI et al.AIDS research and human retroviruses. 2011, Vol 27, Num 1, pp 47-55, issn 0889-2229, 9 p.Article

Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitor, reduces cell growth and promotes differentiationMANGIACASALE, Rosamaria; PITTOGGI, Carmine; LAVIA, Patrizia et al.Oncogene (Basingstoke). 2003, Vol 22, Num 18, pp 2750-2761, issn 0950-9232, 12 p.Article

Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patientsALLAVENA, Clotilde; FERRE, Virginie; LAUNAY, Odile et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 3, pp 300-306, issn 1525-4135, 7 p.Article

Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitorFERRIS, Robert G; HAZEN, Richard J; SHORT, Steven A et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 10, pp 4046-4051, issn 0066-4804, 6 p.Article

Less than 95% adherence to nonnudeoside reverse-transcriptase inhibitor therapy can lead to viral suppressionBANGSBERG, David R.Clinical infectious diseases. 2006, Vol 43, Num 7, pp 939-944, issn 1058-4838, 6 p.Article

A Novel Molecular Mechanism of Dual Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase InhibitorsNIKOLENKO, Galina N; DELVIKS-FRANKENBERRY, Krista A; PATHAK, Vinay K et al.Journal of virology. 2010, Vol 84, Num 10, pp 5238-5249, issn 0022-538X, 12 p.Article

Modulation of human BCRP (ABCG2) activity by anti-HIV drugsWEISS, Johanna; ROSE, Johanna; HENRIKE STORCH, Caroline et al.Journal of antimicrobial chemotherapy (Print). 2007, Vol 59, Num 2, pp 238-245, issn 0305-7453, 8 p.Article

No pol Mutation is Associated Independently with the Lack of Immune Recovery in Patients Infected with HIV and Failing Antiretroviral TherapyGIANOTTI, Nicola; GALLI, Laura; DI GIAMBENEDETTO, Simona et al.Journal of medical virology. 2011, Vol 83, Num 3, pp 391-398, issn 0146-6615, 8 p.Article

Prevention of HIV-1 infection by platinum triazinesVZOROV, A. N; BHATTACHARYYA, D; MARZILLI, L. G et al.Antiviral research. 2005, Vol 65, Num 2, pp 57-67, issn 0166-3542, 11 p.Article

Efficacy, Safety, and Tolerability of Etravirine With and Without Darunavir/Ritonavir or Raltegravir in Treatment-Experienced Patients: Analysis of the Etravirine Early Access Program in the United StatesTOWNER, William; LALEZARI, Jacob; HOOGSTOEL, Annemie et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 53, Num 5, pp 614-618, issn 1525-4135, 5 p.Article

The pharmacology of antiretroviral nucleoside and nucleotide reverse transcriptase inhibitors : Implications for once-daily dosingBACK, David J; BURGER, David M; FLEXNER, Charles W et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, pp S1-S23, issn 1525-4135, SUP1Article

Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in soweto, South Africa and Abidjan, Côte d'IvoireMARTINSON, Neil A; EKOUEVI, Didier K; VIHO, Ida et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, Num 2, pp 206-209, issn 1525-4135, 4 p.Article

Nonnucleoside reverse transcriptase inhibitor phenotypic hypersusceptibility can be demonstrated in different assaysSHULMAN, Nancy S; DELGADO, Jamael; BOSCH, Ronald J et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 1, pp 78-81, issn 1525-4135, 4 p.Article

Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patientsFÄTKENHEUER, Gerd; STASZEWSKI, Schlomo; PLETTENBURG, Andreas et al.AIDS (London). 2009, Vol 23, Num 16, pp 2117-2124, issn 0269-9370, 8 p.Article

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infectionHAUBRICH, Richard H; RIDDLER, Sharon A; RIBAUDO, Heather et al.AIDS (London). 2011, Vol 25, Num 18, pp 2269-2278, issn 0269-9370, 10 p.Article

Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimenFOX, Zoe; PHILLIPS, Andrew; COHERE, Cal et al.AIDS (London). 2008, Vol 22, Num 17, pp 2279-2289, issn 0269-9370, 11 p.Article

Effects of Different Meal Compositions and Fasted State on the Oral Bioavailability of EtravirineSCHÖLLER-GYÜRE, Monika; BOFFITO, Marta; POZNIAK, Anton L et al.Pharmacotherapy. 2008, Vol 28, Num 10, pp 1215-1222, issn 0277-0008, 8 p.Article

Antiviral Activity of MK-4965, a Novel Nonnucleoside Reverse Transcriptase InhibitorLAI, Ming-Tain; MUNSHI, Vandna; TOUCH, Sinoeun et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 6, pp 2424-2431, issn 0066-4804, 8 p.Article

Reverse Transcriptase Inhibitors as Potential Colorectal MicrobicidesHERRERA, Carolina; CRANAGE, Martin; MCGOWAN, Ian et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 1797-1807, issn 0066-4804, 11 p.Article

How common is the non-nucleoside reverse transcriptase inhibitor mutation E138K in clinical practice?BRADSHAW, Daniel; MANDALIA, Sundhiya; NELSON, Mark et al.The Journal of infection. 2011, Vol 63, Num 2, pp 172-173, issn 0163-4453, 2 p.Article

Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance : evidence of transmitted resistance in rural South AfricaBARTH, Roos E; WENSING, Annemarie M; TEMPELMAN, Hugo A et al.AIDS (London). 2008, Vol 22, Num 16, pp 2210-2212, issn 0269-9370, 3 p.Article